Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers
Authors
Keywords
-
Journal
Immunity
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-30
DOI
10.1016/j.immuni.2023.09.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
- (2022) Ricardo A. Chaurio et al. IMMUNITY
- Targeting IDH1/IDH2 mutations in gliomas
- (2022) Macarena I. de la Fuente CURRENT OPINION IN NEUROLOGY
- Neglected no more: B cell-mediated anti-tumor immunity
- (2022) Jose R. Conejo-Garcia et al. SEMINARS IN IMMUNOLOGY
- When secretion turns into excretion – the different roles of IgA
- (2022) Richard A. Strugnell Frontiers in Immunology
- Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
- (2021) Hao Wei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IgA transcytosis and antigen recognition govern ovarian cancer immunity
- (2021) Subir Biswas et al. NATURE
- IDH1 and IDH2 Mutations in Colorectal Cancers
- (2021) Jialing Huang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Acquired Resistance to KRASG12C Inhibition in Cancer
- (2021) Mark M. Awad et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
- (2021) Angelene Richards et al. Human Vaccines & Immunotherapeutics
- B cells and cancer
- (2021) Victor Engelhard et al. CANCER CELL
- IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer
- (2021) Gunjan Mandal et al. CANCER RESEARCH
- Rab11-FIP1 and Rab11-FIP5 Regulate pIgR/pIgA Transcytosis through TRIM21-Mediated Polyubiquitination
- (2021) Xuxu Fan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
- (2021) Xiaolun Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
- (2020) Jenny Y. Xue et al. NATURE
- IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
- (2020) Erika F. Rodriguez et al. Cancer Medicine
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
- (2020) David S. Hong et al. NEW ENGLAND JOURNAL OF MEDICINE
- When Therapeutic IgA Antibodies Might Come of Age
- (2020) Delphine Sterlin et al. PHARMACOLOGY
- Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
- (2018) Tobias Welte et al. INTENSIVE CARE MEDICINE
- Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
- (2017) Seung-Min Shin et al. Nature Communications
- Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
- (2017) Andrea E. Calvert et al. Cell Reports
- Trametinib Drives T-cell–Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis
- (2016) Michael J. Allegrezza et al. CANCER RESEARCH
- Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas
- (2015) Hector H Li-Chang et al. BMC CANCER
- Recycling endosomes
- (2015) James R Goldenring CURRENT OPINION IN CELL BIOLOGY
- Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
- (2015) Saskia Meyer et al. mAbs
- IgA as therapeutic antibody
- (2015) Jeanette H.W. Leusen MOLECULAR IMMUNOLOGY
- Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway
- (2015) Xiaolin Nan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ras moves to stay in place
- (2015) Malte Schmick et al. TRENDS IN CELL BIOLOGY
- Dynamics of KRas on endosomes: involvement of acidic phospholipids in its association
- (2014) Mariona Gelabert-Baldrich et al. FASEB JOURNAL
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells
- (2012) V. Pascal et al. HAEMATOLOGICA
- Structure and function relationships in IgA
- (2011) J M Woof et al. Mucosal Immunology
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
- (2009) David Capper et al. BRAIN PATHOLOGY
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search